Article ID,Publication Year,Reference,US$/QALY *,Ratio Description,PubMed ID,Target Population,Intervention Description,Title,Comparator Description,Impact
2018-01-26127,2018,Nuhoho 2018 Curr Med Res Opin,Cost-Saving,Paliperidone palmitate VERSUS Standard/Usual Care- Oral antipsychotics IN Specific disease- Schizophrenia; Age- Adult; Gender- Both; Country- United Arab Emirates (UAE).,29292670,Specific disease- Schizophrenia; Age- Adult; Gender- Both; Country- United Arab Emirates (UAE).,Paliperidone palmitate,Economic evaluation of paliperidone palmitate once monthly for treating chronic schizophrenia patients in the United Arab Emirates.,Standard/Usual Care- Oral antipsychotics,SE
2014-01-17269,2014,Livingston 2014 Lancet Psychiatry,Cost-Saving,"START psychological manual-based coping intervention. VERSUS Standard/Usual Care- Treatment as usual: medical, psychological, and social, and is supposed to consist of assessment, diagnosis and information-giving, risk assessment and managementmedical, psychological, and social, and is supposed to consist of assessment, diagnosis and information-giving, risk assessment and management, drug treatment, cognitive-stimulation therapy, practical support, treatment of neuropsychiatric and cognitive symptoms, assessment of capacity to make long-term decisions an IN Healthy; Age- 41 to 64 years, >=65 years; Gender- Both; Country- United Arab Emirates.",26361313,"Healthy; Age- 41 to 64 years, >=65 years; Gender- Both; Country- United Arab Emirates.",START psychological manual-based coping intervention.,"Long-term clinical and cost-effectiveness of psychological intervention for family carers of people with dementia: a single-blind, randomised, controlled trial.","Standard/Usual Care- Treatment as usual: medical, psychological, and social, and is supposed to consist of assessment, diagnosis and information-giving, risk assessment and managementmedical, psychological, and social, and is supposed to consist of assessment, diagnosis and information-giving, risk assessment and management, drug treatment, cognitive-stimulation therapy, practical support, treatment of neuropsychiatric and cognitive symptoms, assessment of capacity to make long-term decisions an",SE
2014-01-16298,2014,Treharne 2014 Appl Health Econ Health Policy,Cost-Saving,Peritoneal dialysis (PD) (39% uptake) and in-centre haemodialysis haemodialysis (HD) VERSUS peritoneal dialysis (PD) (22% uptake) IN Specific disease- endstage renal disease (ESRD); Age- Adult; Gender- Both; Country- United Arab Emirates.,25017433,Specific disease- endstage renal disease (ESRD); Age- Adult; Gender- Both; Country- United Arab Emirates.,Peritoneal dialysis (PD) (39% uptake) and in-centre haemodialysis haemodialysis (HD),Peritoneal dialysis and in-centre haemodialysis: a cost-utility analysis from a UK payer perspective.,peritoneal dialysis (PD) (22% uptake),SE
1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
